Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Physiol ; 471: 245-68, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8120806

RESUMEN

1. The effects of phorbol esters on evoked and spontaneous excitatory neurotransmission were studied in the CA1 area in the in vitro hippocampal slice preparation of the rat. Experiments were conducted using field potential recording and whole-cell voltage clamp of CA1 pyramidal neurons. 2. Pyramidal cells dialysed during whole-cell recording with EGTA-containing electrode solutions, unable to support the induction of long-term potentiation (LTP), still showed robust phorbol ester-induced potentiation of excitatory synaptic transmission. 3. Spontaneous miniature excitatory postsynaptic currents (EPSCs), recorded in whole-cell voltage clamp in the presence of tetrodotoxin and picrotoxin, had amplitudes ranging from 4 to 40 pA and occurred at an average frequency of 0.8-5 Hz. Neither the amplitude nor the frequency of spontaneous EPSCs was altered by cadmium, dihydropyridines, or omega-conotoxin GVIA. 4. The phorbol ester 4-beta-phorbol 12,13-diacetate increased the frequency of spontaneous miniature EPSCs without changing the shape of the EPSC amplitude distribution, suggesting that phorbol esters exert their potentiating effects presynaptically. 5. Blockade of voltage-dependent calcium channels with cadmium attenuated the phorbol-induced increase in spontaneous miniature EPSCs frequency. The phorbol ester-induced increase in miniature EPSC frequency was also attenuated by dihydropyridines, but not by omega-conotoxin GVIA. 6. Unlike spontaneous synaptic currents, stimulus-evoked synaptic currents were reduced by omega-conotoxin but not by nifedipine. 7. We conclude that the phorbol ester increases spontaneous release of glutamate by modulating an L-type channel that does not participate in stimulus-evoked neurotransmitter release.


Asunto(s)
Hipocampo/efectos de los fármacos , Ésteres del Forbol/farmacología , Transmisión Sináptica/efectos de los fármacos , omega-Conotoxinas , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Animales , Cadmio/farmacología , Calcio/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Potenciales Evocados/efectos de los fármacos , Potenciales Evocados/fisiología , Hipocampo/fisiología , Técnicas In Vitro , Masculino , Péptidos/farmacología , Células Piramidales/efectos de los fármacos , Células Piramidales/fisiología , Ratas , Ratas Sprague-Dawley , Transmisión Sináptica/fisiología
2.
Cell ; 73(7): 1281-90, 1993 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-8100740

RESUMEN

Synaptotagmin is one of the major integral membrane proteins of synaptic vesicles. It has been postulated to dock vesicles to their release sites, to act as the Ca2+ sensor for the release process, and to be a fusion protein during exocytosis. To clarify the function of this protein, we have undertaken a genetic analysis of the synaptotagmin gene in Drosophila. We have identified five lethal alleles of synaptotagmin, at least one of which lacks detectable protein. Surprisingly, however, many embryos homozygous for this null allele hatch and, as larvae, crawl, feed, and respond to stimuli. Electrophysiological recordings in embryonic cultures confirmed that synaptic transmission persists in the null allele. Therefore, synaptotagmin is not absolutely required for the regulated exocytosis of synaptic vesicles. The lethality of synaptotagmin in late first instar larvae is probably due to a perturbation of transmission that leaves the main apparatus for vesicle docking and fusion intact.


Asunto(s)
Proteínas de Unión al Calcio , Drosophila/metabolismo , Glicoproteínas de Membrana/genética , Proteínas del Tejido Nervioso/genética , Animales , Análisis Mutacional de ADN , Electrofisiología , Genes Letales , Glicoproteínas de Membrana/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Neurotransmisores/metabolismo , Vesículas Sinápticas/metabolismo , Sinaptotagminas
3.
Hippocampus ; 2(1): 59-64, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1339193

RESUMEN

Previous studies have shown that either norepinephrine (NE) or isoproterenol (ISO) enhances the slope of the field excitatory postsynaptic potential (EPSP) in the dentate gyrus of the rat hippocampal formation. In contrast, NE and ISO cause no increase in excitatory transmission in area CA1 of the hippocampus. The molecular mechanism underlying this brain region-specific increase in synaptic transmission is not known. The phosphorylation of synapsin I and synapsin II, two homologous presynaptic vesicle-associated proteins, is thought to promote neurotransmitter release. The authors have observed previously NE- and ISO-enhanced phosphorylation of synapsins I and II in the dentate gyrus. The purpose of this study was to determine whether ISO-stimulated phosphorylation also occurs in the CA1, where ISO has no effect on excitatory neurotransmission. These studies were correlated with electrophysiological studies in in vitro hippocampal slices. Superfusion of slices with ISO resulted in an increase in EPSP slope in the dentate but not in area CA1. The enhanced dentate EPSP returned to baseline levels within 30 minutes of washout of the drug. Isoproterenol produced corresponding increases in the phosphorylation of the synapsins in dentate slices but had no effect on these proteins in CA1 slices. Moreover, in dentate slices exposed to a 30-minute wash following incubation with ISO, phosphorylation of the synapsins returned to control levels. This close temporal and brain regional correlation between ISO stimulation of both synapsin phosphorylation and synaptic transmission suggests that the synapsin proteins may play a role in the synaptic potentiation produced by ISO in the dentate.


Asunto(s)
Hipocampo/fisiología , Isoproterenol/farmacología , Tractos Piramidales/fisiología , Sinapsis/fisiología , Sinapsinas/metabolismo , Transmisión Sináptica/efectos de los fármacos , Animales , Autorradiografía , Estimulación Eléctrica , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Técnicas In Vitro , Cinética , Masculino , Fosfatos/metabolismo , Radioisótopos de Fósforo , Fosforilación , Tractos Piramidales/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Sinapsis/efectos de los fármacos , Sinapsinas/aislamiento & purificación , Factores de Tiempo
4.
Proc Natl Acad Sci U S A ; 88(6): 2361-5, 1991 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-1900942

RESUMEN

A number of recent reports have suggested that norepinephrine (NE) produces a form of synaptic enhancement that resembles long-term potentiation (LTP). LTP, thought to be an electrophysiological correlate of memory, in part involves an augmentation of transmitter release. Although the effects of NE have not been unequivocally linked to LTP, it is clear that NE can produce increased transmitter release in the dentate gyrus of the hippocampus. The purpose of this study was to determine whether NE was capable of enhancing the phosphorylation of synapsin I and synapsin II, two homologous phosphoproteins thought to be involved in modulation of neurotransmitter release. NE (10 microM) and isoproterenol (250 nM) produced an increase in the phosphorylation of synapsin I and synapsin II in dentate slices from young rats. Phosphorylation site analysis of synapsin I, performed by limited proteolysis, indicated that NE and isoproterenol increased the phosphorylation of synapsin I at sites modified by Ca2+/calmodulin-dependent protein kinase II as well as cAMP-dependent protein kinase. These data demonstrate that NE stimulates the phosphorylation of synapsin I at its Ca2+/calmodulin-dependent protein kinase II site, which is a site that has been shown to regulate the effect of synapsin I on neurotransmitter release. We have also examined the effects of NE and isoproterenol on synapsin phosphorylation in dentate slices prepared from aged animals. Such animals have previously been shown to exhibit deficits in NE sensitivity as well as significant impairment in their ability to exhibit LTP. Neither NE nor isoproterenol stimulated synapsin phosphorylation in slices prepared from aged animals. Interestingly, the basal level of phosphorylation of the synapsin proteins was higher in slices prepared from aged animals. This higher basal level of phosphorylation may underlie the failure of aged animals to exhibit NE-stimulated increases in phosphorylation of the synapsin proteins. We hypothesize that the beta-adrenergic agonist-stimulated phosphorylation of synapsin I and synapsin II in young rats plays a role in the increase in transmitter release produced by NE in the dentate. Thus, the failure of the aged rats to show such phosphorylation may underlie, in part, their failure to exhibit normal responsiveness to NE. Moreover, these deficits in synapsin phosphorylation may also play some role in the deficits in plasticity seen in aged rats.


Asunto(s)
Hipocampo/crecimiento & desarrollo , Isoproterenol/farmacología , Proteínas del Tejido Nervioso/metabolismo , Neuropéptidos/metabolismo , Norepinefrina/farmacología , Proteínas Quinasas/farmacología , Envejecimiento , Animales , Proteínas del Citoesqueleto/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Técnicas In Vitro , Cinética , Proteínas Asociadas a Microtúbulos/metabolismo , Proteínas del Tejido Nervioso/aislamiento & purificación , Neuropéptidos/aislamiento & purificación , Fosforilación , Ratas , Ratas Endogámicas F344 , Sinapsinas
6.
Neurobiol Aging ; 11(6): 591-6, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-1980720

RESUMEN

Previous electrophysiological studies in aged rats have revealed a number of deficits in noradrenergic neurotransmission in the central nervous system. Such deficits include subsensitivity to the depressant effects of norepinephrine on cerebellar Purkinje neurons, which has been attributed specifically to altered beta adrenergic receptor-mediated processes. The objective of this study was to determine which beta adrenergic receptor subtype, beta 1 or beta 2, is responsible for this age-related subsensitivity. The effects of beta 1 and beta 2 agonists on spontaneous activity of Purkinje neurons was first examined in young rats and the selectivity of these agents was validated using selective beta 1 and beta 2 antagonists. The effects of the selective beta 1 and beta 2 agonists were then compared in young (3-month-old) and aged (18- and 26-month-old) Fischer 344 rats. These agents were applied to Purkinje neurons by pressure microejection from multibarreled micropipettes and the change in neuronal action potential discharge rate was recorded. Both dobutamine, a beta 1-selective agonist, and zinterol, a beta 2-selective agonist, induced dose-dependent inhibitions of Purkinje cell firing rate. Dobutamine-induced inhibitions were blocked by the selective beta 1 antagonist, ICI 89406 and not by the beta 2-selective antagonist, ICI 118551; conversely, zinterol-induced inhibitions were not blocked by ICI 89406 but were blocked by the presence of ICI 118551. Purkinje neurons of both groups of aged rats were significantly less sensitive to locally applied dobutamine than Purkinje cells of young rats.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Agonistas Adrenérgicos beta/farmacología , Envejecimiento/fisiología , Cerebelo/citología , Células de Purkinje/efectos de los fármacos , Potenciales de Acción/efectos de los fármacos , Antagonistas Adrenérgicos beta/farmacología , Animales , Corteza Cerebelosa/efectos de los fármacos , Cerebelo/efectos de los fármacos , Dobutamina/antagonistas & inhibidores , Dobutamina/farmacología , Electrofisiología , Etanolaminas/antagonistas & inhibidores , Etanolaminas/farmacología , Isoproterenol/farmacología , Masculino , Norepinefrina/farmacología , Ratas , Ratas Endogámicas F344
7.
Neuropharmacology ; 29(10): 909-16, 1990 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2175016

RESUMEN

A large body of electrophysiological data has supported the hypothesis that an important role of norepinephrine in the central nervous system is to modulate the actions of other transmitter systems, particularly those utilizing the amino acid neurotransmitters. Noradrenergic potentiation of inhibitory responses, induced by locally-applied or synaptically-released gamma-aminobutyric acid (GABA) on cerebellar Purkinje neurons, has been observed by a number of investigators, who have suggested that activation of beta-adrenergic receptors plays a critical role in mediating this modulatory effect of norepinephrine (NE). Two postsynaptic receptors for GABA, termed A and B, have been identified and both subtypes have been found in the cerebellum of the rat. The purposes of this investigation were first to identify the subtype(s) of GABA receptor responsible for mediating the inhibitory effects of locally-applied GABA in the cerebellar cortex and second to identify which subtype of GABA receptor is modulated by a beta-adrenergic input. Inhibitory responses of cerebellar Purkinje neurons, in urethane-anesthetized rats, to iontophoretic or pressure-applied isoguvacine, a selective GABAA agonist, to baclofen, a GABAB agonist or to GABA itself, were examined before, during and after local application of isoproterenol or norepinephrine. Isoguvacine, but not baclofen, induced consistent and dose-dependent inhibition of the firing of Purkinje cells. At ejection currents that had no effect on spontaneous firing rate, iontophoretically-applied isoproterenol potentiated isoguvacine-induced inhibition. These data suggest that GABAA, rather than GABAB receptors, mediate GABA-induced inhibitions of cerebellar Purkinje neurons. Moreover, it appears that the modulation of GABA function by beta adrenergic agonists involves an interaction between a beta-adrenergic input and the GABAA receptor complex.


Asunto(s)
Corteza Cerebelosa/fisiología , Isoproterenol/farmacología , Receptores de GABA-A/fisiología , Ácido gamma-Aminobutírico/farmacología , Potenciales de Acción/efectos de los fármacos , Animales , Baclofeno/farmacología , Corteza Cerebelosa/efectos de los fármacos , Sinergismo Farmacológico , Ácidos Isonicotínicos/farmacología , Masculino , Neuronas/efectos de los fármacos , Neuronas/fisiología , Células de Purkinje/efectos de los fármacos , Células de Purkinje/fisiología , Ratas , Ratas Endogámicas F344 , Receptores de GABA-A/efectos de los fármacos
8.
J Pharmacol Exp Ther ; 254(2): 539-45, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1974642

RESUMEN

The effects of the selective dopamine D1 and D2 receptor agonists, SKF 38393 and N-0437, respectively, on the firing rate of medial prefrontal cortex (PFC) neurons were studied in young (3-5 months old), and aged (18 and 26 months old) Fischer 344 rats. Multibarrel glass micropipettes, filled with 1 mM SKF 38393 and N-0437, were lowered into the anteromedial cortical target area (PFC) of the mesocortical dopamine system in urethane-anesthetized animals. The drug solutions were locally applied by pressure ejection. In young rats, both agonists produced dose-dependent and reversible reductions in firing rates. However, the D2 agonist was approximately 10 times more potent than the D1 agonist in suppressing firing rate. Even at the highest doses, SKF 38393 rarely produced complete cessation of firing in PFC cells. Moreover, no evidence of synergism was observed when the two drugs were simultaneously applied. PFC neurons in aged rats were significantly subsensitive to locally applied SKF 38393, whereas no change in sensitivity to N-0437 was observed. These results suggest that both D1 and D2 receptors are present in the PFC and that agonist occupancy of each of these receptors elicits an inhibition of PFC neuron discharge; furthermore, these data suggest an age-related change in D1 dopamine receptor-mediated processes with no concomitant change in processes linked to the activation of D2 dopamine processes.


Asunto(s)
2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina/farmacología , Envejecimiento/metabolismo , Corteza Cerebral/efectos de los fármacos , Dopaminérgicos/farmacología , Antagonistas de Dopamina , Naftalenos/farmacología , Tetrahidronaftalenos/farmacología , Tiofenos/farmacología , 2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina/antagonistas & inhibidores , Animales , Benzamidas/farmacología , Benzazepinas/farmacología , Corteza Cerebral/metabolismo , Corteza Cerebral/fisiología , Relación Dosis-Respuesta a Droga , Electrofisiología , Masculino , Neuronas/efectos de los fármacos , Ratas , Ratas Endogámicas F344 , Tetrahidronaftalenos/antagonistas & inhibidores , Tiofenos/antagonistas & inhibidores
9.
Brain Res ; 462(2): 242-51, 1988 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-2847850

RESUMEN

We have investigated the receptor subtype(s) mediating the noradrenergic inhibition of cerebellar Purkinje cell spontaneous firing rate using local application of specific agonists and antagonists, in situ, via pressure microejection. Extracellular action potentials were recorded from Purkinje neurons in anesthetized Fischer 344 rats. Timolol, a beta-receptor antagonist, did not affect norepinephrine (NE)-induced inhibition in 9 of 12 cells studied. Phentolamine, an alpha-receptor antagonist, blocked the effect of NE in 8 of 11 cells. To further determine the subtype of alpha-receptor involved, the effects of the alpha 1-antagonist prazosin and alpha 2-antagonists idazoxan and yohimbine were examined. While prazosin had no effect on NE-mediated inhibition, both idazoxan and yohimbine blocked NE effects. Idazoxan was also successful in blocking phencyclidine (PCP), an indirect noradrenergic agonist. The inhibitory action of NE upon Purkinje cell firing rate was mimicked by the selective alpha 2-agonist clonidine; this action of clonidine was blocked by idazoxan but not by timolol or prazosin. In addition, the alpha 1-adrenergic agonist phenylephrine and the beta-adrenergic agonist isoproterenol inhibited Purkinje cell firing rate. Phenylephrine effects were blocked by prazosin but not by timolol or idazoxan. Isoproterenol-induced inhibition was blocked by timolol but not phentolamine. Taken together, these studies suggest that both alpha- and beta-receptors alter Purkinje cell firing rate; the depressant action of locally applied NE, however, seems to be mediated primarily via an alpha 2-adrenergic receptor.


Asunto(s)
Dioxanos/farmacología , Dioxinas/farmacología , Inhibición Neural/efectos de los fármacos , Norepinefrina/farmacología , Células de Purkinje/fisiología , Receptores Adrenérgicos/fisiología , Yohimbina/farmacología , Potenciales de Acción/efectos de los fármacos , Animales , Idazoxan , Norepinefrina/metabolismo , Fenciclidina/farmacología , Fentolamina/farmacología , Células de Purkinje/efectos de los fármacos , Células de Purkinje/metabolismo , Ratas , Ratas Endogámicas F344 , Receptores Adrenérgicos/efectos de los fármacos , Receptores Adrenérgicos alfa/efectos de los fármacos , Receptores Adrenérgicos alfa/fisiología , Receptores Adrenérgicos beta/efectos de los fármacos , Receptores Adrenérgicos beta/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA